Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
7.19
+0.21 (3.01%)
Aug 1, 2025, 2:45 PM CST
3.01%
Market Cap3.65B
Revenue (ttm)1.95B
Net Income (ttm)62.44M
Shares Out534.07M
EPS (ttm)0.12
PE Ratio60.22
Forward PEn/a
Dividend0.15 (2.15%)
Ex-Dividend DateJun 5, 2025
Volume30,153,663
Average Volume9,401,341
Open6.98
Previous Close6.98
Day's Range6.93 - 7.35
52-Week Range5.03 - 8.87
Beta0.57
RSI69.93
Earnings DateAug 30, 2025

About Altus Power

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, nourishing and soothing, tonic products, cold and cough, children's medicine, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate ... [Read more]

Sector Healthcare
Founded 1990
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2024, SHA:600613's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.

Financial Statements

News

There is no news available yet.